Efficacy of the Nanodropper Device on Pupillary Dilation

University of California San Francisco (UCSF)

Status: Completed

Conditions: Dilation

Treatments: Device: Nanodropper; Device: Standard Eye Dropper

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT05274321

20-32530-OBS

Details and patient eligibility

About

Prescription eye drop bottles elute drops that exceed the capacity of the human eye by five times. This study describes performing in clinic dilation using a novel solution for combating medical waste with Nanodropper, an eye drop bottle adapter that creates smaller eye drops.

Enrollment: 50 patients

Sex: All

Ages: 2 to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants under the age of 18 years old

Exclusion criteria

• Participants 18 years and older
• Pupillary or anterior segment abnormality
• Participants with pre-existing health conditions that would prevent pupillary dilation.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups

Pediatric Participant's Eyes Using Standard Pupilary Dilation

Active Comparator group

Description:

Consenting pediatric participants will undergo standard pupillary dilation in one eye.

Treatment:

Device: Standard Eye Dropper

Pediatric Participant's Eyes using Nanodropper attachment

Experimental group

Description:

Consenting pediatric participants will undergo pupillary dilation in the second eye using the Nanodropper attachment.

Treatment:

Device: Nanodropper